House Sponsors: O'BRIEN-HASSERT-BURKE-LOPEZ-HAMOS, LYONS,JOSEPH, CURRY,JULIE, CROTTY, FOWLER, PERSICO, HOFFMAN, WAIT, BRADLEY, DAVIS,MONIQUE, HARRIS AND MCGUIRE. Senate Sponsors: SYVERSON-MAHAR-FAWELL-SHADID-MUNOZ Short description: DISPENSING GENERIC DRUGS Synopsis of Bill as introduced: Amends the Pharmacy Practice Act and the Illinois Food, Drug and Cosmetic Act. Provides that pharmacists may substitute generic brand drugs, provided that the selected drug has been rated therapeutically equivalent to the prescribed drug in the Orange book or meets other criteria. Effective immediately. HOUSE AMENDMENT NO. 1. Deletes a provision in the Illinois Food, Drug and Cosmetic Act that provides that the determination of drug products that have not been rated therapeutically equivalent in the Orange book, but that may be selected shall be recommended by a Technical Advisory Council of the Department. BALANCED BUDGET NOTE, H-AM 1 (Bureau of the Budget) Since this bill is not a supplemental appropriation bill, the Balanced Budget Note Act is inapplicable. JUDICIAL NOTE, H-AM 1 (Administrative Office of Ill. Courts) There would be neither a decrease nor an increase in the number of judges needed. GOVERNOR'S AMENDATORY VETO MESSAGE Recommends changing the bill to provide that the therapeutically equivalent generic brand that the pharmacist may substitute for name brands may not be a critical dose drug and that the Technical Advisory Council be allowed to consider drugs that require a prescription and are legally marketed in the United States according to FDA regula- tions. Recommends a definition for "critical dose drug". Last action on Bill: BILL DEAD-AMENDATORY VETO Last action date: 99-11-18 Location: House Amendments to Bill: AMENDMENTS ADOPTED: HOUSE - 1 SENATE - 0 END OF INQUIRY Full Text Bill Status